The big cranes doing the heaviest lifting for the $100 million in repairs and renovations to the still-idle McNeil Consumer Healthcare manufacturing plant in Fort Washington are gone.
Many employees in various departments show up daily, but they aren't making Tylenol, Motrin, and Benadryl, which are mostly absent from drugstore shelves in nearby Ambler as the cold-and-flu season approaches.
The heavy profits from those products are also missing from the balance sheet of Johnson & Johnson, the parent company - a major point made by corporate officials last week as they explained a disappointing third-quarter earnings report.
Artigo interessante sobre os Recalls obtidos da J&J no último ano, leia mais no link acima.
Nenhum comentário:
Postar um comentário